Hawley says FDA nominee Overton agreed to new mifepristone safety-study timeline
Sen. Josh Hawley’s office told Fox News Digital that FDA commissioner nominee Dr. Heidi Overton committed to set binding study parameters for mifepristone. Hawley’s office said the Trump administration aims to finalize the safety study by March 2027.
This is HUB News’s original summary. Read the complete report at Fox News.